Clinical Trial Update: A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

View source ↗

Summary

A clinical trial update for safety evaluation of Tazemetostat in Japanese participants with relapsed or refractory follicular lymphoma harboring EZH2 mutation; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Tazemetostat (tazemetostat)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Lymphoma, Follicular | Status: ACTIVE_NOT_RECRUITING